To view the clinical trials Valley currently has available, please use the search field or select a clinical specialty from the drop-down list below. Be sure to check back frequently, as we are always adding new studies.
For more information about any of our clinical trials, please email [email protected] or call 201-447-8453. (For cancer clinical trials, please call 201-634-5792.)
A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation (PFA) Versus Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
BradycArdia Pacemaker With AV Interval Modulation for Blood Pressure Treatment
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
BATwire Implant Kit
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
His Bundle Corrective Pacing in Heart Failure (HIS-CRT)
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants With Atrial Fibrillation
Principal Investigator(s): Dan L. Musat, MD
Status: Open and enrolling
Comparison of left bundle branch area versus right ventricular septal pacing in patients with high-degree conduction disease after transcatheter aortic valve replacement: Left Bundle BRAVE study
Principal Investigator(s): Mohammadali Habibi, MD
Status: Open and enrolling
Cardiac Resynchronization Therapy Using His/Left Bundle Branch Pacing vs Biventricular Pacing With a Left Ventricular Epicardial Lead in Patients With Heart Failure (HF) With Left Ventricular Ejection Fraction (LVEF)≤50% and With Either a Wide QRS Complex (>130 ms) or With/Anticipated >40% Pacing Randomized Clinical Trial
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
A Prospective, Multi-center, Non-randomized, Single Arm Open Label Study of 620 Subjects Receiving the OPTIMIZER Smart With CCM Therapy as Standard of Care
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling